Showing 9391-9400 of 20873 results for "".
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
https://reachmd.com/programs/spotlight-subcutaneous-cancer-immunotherapies/nanrilkefusp-alfa-a-promising-subcutaneous-il-15r-superagonist/32991/Read about the mechanisms, safety, and efficacy of nanrilkefusp alfa, an IL-15 receptor βγ superagonist designed to stimulate NK and CD8+ T cells.Managing Partial Response in IBS-C Care
https://reachmd.com/programs/clinicians-roundtable/managing-partial-response-ibs-c/51042/Irritable bowel syndrome with constipation (IBS-C) often presents with persistent symptoms despite initial therapy, requiring a more comprehensive approach to assessment and management. As a result, clinicians must evaluate global symptom burden, quality of life, and patient preferences to determineHow the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
https://reachmd.com/programs/project-oncology/2025-imwg-guidelines-sequencing-rr-myeloma/39922/This is a non-certified educational series produced and controlled by ReachMD. The latest International Myeloma Working Group (IMWG) guidelines emphasize immune function, relapse timing, and therapeutic intent to guide the sequencing of T-cell-redirecting therapies in relapsed/refractory (R/R) multiUnlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
https://reachmd.com/programs/frontlines-iga-nephropathy/unlocking-early-detection-of-iga-nephropathy-the-critical-role-of-timely-diagnosis/26945/Here’s how early identification of IgA nephropathy can improve patient outcomes.How Delayed Colorectal Cancer Screening Impacts Quality of Life
https://reachmd.com/programs/clinicians-roundtable/delayed-colorectal-cancer-screening-quality-of-life/56448/Delayed colorectal cancer screening can significantly impact not only clinical outcomes, but also patients’ long-term quality of life. Tune in to hear Dr. Christopher Cann share his insights on these lasting consequences, including the need for more extensive surgery and systemic therapies, the burdGut Microbiome Mechanisms Shaping Immune Responses to Allergens
https://reachmd.com/programs/clinicians-roundtable/gut-microbiome-immune-response-allergens/54220/Emerging research is redefining the role of the gut microbiome in food allergy and immune tolerance. Here to share some of the most groundbreaking findings is Dr. Mustafa Ozcam. He discusses how gut microbes metabolize allergenic proteins, shape immune development, and serve as potential biomarkersImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
https://reachmd.com/programs/medical-industry-feature/immune-imprinting-and-vaccines-rethinking-the-first-exposure-to-influenza/26669/Discover the potential role of immune imprinting in shaping how we approach influenza vaccination.Improving Long-Term Adherence to CRC Screening Recommendations
https://reachmd.com/programs/clinicians-roundtable/long-term-adherence-crc-screening/57236/Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abnormal results. But real-world data shows that many patients fall off track over tiAssessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
https://reachmd.com/programs/frontlines-food-allergies/assessing-milk-and-egg-ladders-for-pediatric-ige-mediated-allergies/30037/Find out how milk and egg ladders can help gradually introduce allergenic protein at home to children with IgE-mediated allergies.Rethinking IBS-C Goals: A Patient-Centered Approach
https://reachmd.com/programs/clinicians-roundtable/ibs-c-goals-patient-centered-approach/51044/Irritable bowel syndrome with constipation (IBS-C) is a chronic condition that calls for realistic, patient-centered treatment expectations rather than a focus on cure. Meaningful progress often comes from improving overall symptoms, quality of life, and tailoring care to what matters most to each p